🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As an orthopedic surgeon,father and grandfather I haven’t said anything about these E-Bikes and E-Scooters but I have seen enough. They are extremely dangerous and children shouldn’t be riding these, especially without helmets. You should have to have drivers license to operate

May is coming and going in the same direction …

Over 10,000 patients later… Cerebral protection during TAVR? Still looks good, still doesn’t matter. Stroke @ 72h: 2.2% with vs 2.3% without. p = 0.641 Who exactly are we protecting?

SCAI wants lead-free cath labs and a better work-life balance for cardiologists ⁦Poonam Velagapudi⁩ ⁦Aditya Bharadwaj⁩ ⁦Giorgio A. Medranda MD, FACC, FAHA, FSCAI⁩ ⁦MIЯVΛƬ #IC⁩ ⁦Cardiovascular Business⁩ ⁦SCAI⁩⁩ ⁦David J. Cohen, MD, MSc⁩ ⁦Ankur Kalra⁩ cardiovascularbusiness.com/topics/clinica…

No reflow in Anterior STEMI. IC Epi and Nicardipine: delivered via distal microcatheter. Low-dose systemic NorEpi via central venous access. IVUS vessel. Gentle POBA outflow. IABP and Swan. Wait. Final angiography: with normalization of flow (and Diagonal branch coming back) 👍…

We have a new Lp(a) paper, led by David Erlinge from PROSPECT 2 using IVUS/NIRS. It shows high Lp(a) associates most with vulnerable plaque characteristics, whereas LDL-C with plaque burden. Lp(a) was measured by our UC San Diego Cardiology assay, the only Lp(a) assay I am aware of that is

Congrats Abbott Cardiovascular for U.S. FDA approval of #Tendyne #TMVR in MAC pts with mitral valve disease. This will be the first FDA approval of a TMVR device in the US. Thousands of implants have been done worldwide with 3-5y follow up on the longest survivors. Device is transapical

Mixoma Gigante en Aurícula Derecha Vídeo original de Dr G Rajesh (Gopalan Nair Rajesh) #Cardiotwitter #CardioEd #MedEd #POCUS #TEE

In the field of interventional cardiology, today’s news is that Boston Scientific Corporation has announced the discontinuation of global sales of its ACURATE neo2™ and ACURATE Prime™ aortic valve systems. Over the years, various iterations of this valve have been evaluated in

we talk much about new #TAVI devices, but we talk few about a small tip which has improved our practice - at least mine. Use of suture/plug-based strategy for arterial femoral access closure has reduced dramatically vascular complications, if performed together with eco-guided

Aaron Goodman - “Papa Heme” Having worked in multiple different settings over the past 30 years, I can attest to all these things. The most important part of the job isn’t the setting but rather the culture and institutional support/alignment in terms of mission.

On the basis of current evidence, what is the appropriate action regarding routine early use of beta blocker post-MI which is endorsed as Class 1 LoE A recommendation by 2025 ACS guideline?

#Sharing is learning A Black Mystery Inside the Heart! Have a look at this unusual black spherical structure within the heart—never encountered something like this before. What could it be? I’d love to hear your interpretations.

Another formerly respected journal goes down…

There are bicuspid valves and then there is this subtype(uncommon) - describe the subtype #echofirst WVU CV fellows Chittur Sivaram Edgar Argulian Ritu Thamman MD Nicolas Merke

Alternative access #TAVR via carotid artery. Live case presentation at Cardiovascular Research Foundation #NYValves2025 I find this approach fascinating with clinical data in a large registry to be presented tommorrow Done in less than 30 minutes.

Think of tortuosity as a reason for alternative access during #TAVR! The devices might run out of reach! Another lesson learned #NYValves2025! Learning from TAVR failure sessions! Raj Tayal Cardiovascular Research Foundation

Middle aged man with cryptogenic stroke. Bubble study showed no right to left shunt. What else do you see? #CardioTwitter